BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 3916522)

  • 1. Heart transplantation in Paris, at "La Pitie" Hospital.
    Cabrol C; Gandjbakhch I; Pavie A; Cabrol A; Mattei MF; Leger P
    J Heart Transplant; 1985; 4(5):476-80. PubMed ID: 3916522
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualized immunosuppression in heart transplant recipients.
    Haverich A; Frimpong-Boateng K; Schäfers HJ; Wahlers T; Fieguth HG; Herrmann G; Wonigeit K; Borst HG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2514-5. PubMed ID: 3274552
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuncts to triple-drug therapy after cardiac transplantation: a comparison of Nashville rabbit antithymocyte serum to OKT3.
    Aziz S; Kruse AP; Roby PV; Allen MD; Khan K; Fishbein D
    Transplant Proc; 1994 Oct; 26(5):2721-3. PubMed ID: 7940852
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD
    Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 8. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits of avoidance of induction immunosuppression in heart transplantation.
    Menkis AH; McKenzie FN; Thomson D; Jones M; Pflugfelder P; Kostuk WJ; Stiller CR
    J Heart Transplant; 1989; 8(4):311-4. PubMed ID: 2671316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotopic versus orthotopic heart transplantation.
    Barnard CN; Cooper DK
    Transplant Proc; 1984 Jun; 16(3):886-92. PubMed ID: 6375048
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal function in the immediate postoperative period after heart transplantation using very low initial doses of cyclosporin A].
    Cladellas M; Sánchez JM; Abadal ML; Ballester M; Obrador D; Amengual MJ; Quintana E; Net A; Cámara ML; Padró JM
    Rev Esp Cardiol; 1987; 40 Suppl 2():70-3. PubMed ID: 3331810
    [No Abstract]   [Full Text] [Related]  

  • 15. Monotherapy with cyclosporine in kidney transplantation.
    Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
    [No Abstract]   [Full Text] [Related]  

  • 16. ULF ballistocardiography in human cardiac transplantation.
    Shakespeare T; Reitan JA; Smith NT; Stinson EB; Shumway NE
    Bibl Cardiol; 1971; ():Suppl 27:1-9. PubMed ID: 4935282
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 18. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 19. [After care of kidney transplant patients].
    Castro LA; Eigler J; Land W
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.